Advertisement

Related Videos

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Garth Strohbehn, MD, MPhil, on Applied Clinical Pharmacology in a Crisis: Interventional Pharmacoeconomics and COVID-19

Matthew Seymour, MD: A Clinical Trialist’s Perspective

Welcome and Introduction to Vi3C

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

Advertisement

Advertisement




Nov
12
Today In Oncology
Supportive Care: Most Clinic Staff Prefer People-Focused vs Digital Solutions
Addition of Eryaspase to Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma
Longtime FDA Innovator Appointed as Director of CDER
T-DXd Plus Pertuzumab in HER2-Positive Advanced or Metastatic Breast Cancer
Local Consolidative Therapy Enhances Outcomes With Osimertinib in EGFR-Mutant NSCLC
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo